BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20856930)

  • 1. Triage of women with minor cervical lesions: data suggesting a "test and treat" approach for HPV E6/E7 mRNA testing.
    Sørbye SW; Fismen S; Gutteberg T; Mortensen ES
    PLoS One; 2010 Sep; 5(9):e12724. PubMed ID: 20856930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV E6/E7 mRNA testing is more specific than cytology in post-colposcopy follow-up of women with negative cervical biopsy.
    Sørbye SW; Arbyn M; Fismen S; Gutteberg TJ; Mortensen ES
    PLoS One; 2011; 6(10):e26022. PubMed ID: 21998748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV E6/E7 mRNA versus HPV DNA biomarker in cervical cancer screening of a group of Macedonian women.
    Duvlis S; Popovska-Jankovic K; Arsova ZS; Memeti S; Popeska Z; Plaseska-Karanfilska D
    J Med Virol; 2015 Sep; 87(9):1578-86. PubMed ID: 25880030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-risk human papillomavirus (hrHPV) E6/E7 mRNA testing by PreTect HPV-Proofer for detection of cervical high-grade intraepithelial neoplasia and cancer among hrHPV DNA-positive women with normal cytology.
    Rijkaart DC; Heideman DA; Coupe VM; Brink AA; Verheijen RH; Skomedal H; Karlsen F; Morland E; Snijders PJ; Meijer CJ
    J Clin Microbiol; 2012 Jul; 50(7):2390-6. PubMed ID: 22553244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity, specificity, and clinical value of human papillomavirus (HPV) E6/E7 mRNA assay as a triage test for cervical cytology and HPV DNA test.
    Benevolo M; Vocaturo A; Caraceni D; French D; Rosini S; Zappacosta R; Terrenato I; Ciccocioppo L; Frega A; Giorgi Rossi P
    J Clin Microbiol; 2011 Jul; 49(7):2643-50. PubMed ID: 21525231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV mRNA testing in triage of women with ASC-US cytology may reduce the time for CIN2+diagnosis compared with repeat cytology.
    Sørbye SW; Fismen S; Gutteberg TJ; Mortensen ES; Skjeldestad FE
    Curr Pharm Des; 2013; 19(8):1401-5. PubMed ID: 23016772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive testing of early cervical pre-cancer by detecting human papillomavirus E6/E7 mRNA in cervical cytologies up to high-grade squamous intraepithelial lesions: diagnostic and prognostic implications.
    Varnai AD; Bollmann M; Bankfalvi A; Speich N; Schmitt C; Griefingholt H; Kovács K; Klozoris C; Bollmann R
    Oncol Rep; 2008 Feb; 19(2):457-65. PubMed ID: 18202795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-risk human papillomavirus E6/E7 mRNA and L1 DNA as markers of residual/recurrent cervical intraepithelial neoplasia.
    Persson M; Brismar Wendel S; Ljungblad L; Johansson B; Weiderpass E; Andersson S
    Oncol Rep; 2012 Jul; 28(1):346-52. PubMed ID: 22484610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus (HPV) E6/E7 mRNA as a triage test after detection of HPV 16 and HPV 18 DNA.
    Perez Castro S; Iñarrea Fernández A; Lamas González MJ; Sarán Diez MT; Cid Lama A; Alvarez Martín MJ; Pato Mosquera M; López-Miragaya I; Estévez N; Torres Piñón J; Oña Navarro M
    J Med Virol; 2013 Jun; 85(6):1063-8. PubMed ID: 23588733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triage of women with low-grade cervical lesions--HPV mRNA testing versus repeat cytology.
    Sørbye SW; Arbyn M; Fismen S; Gutteberg TJ; Mortensen ES
    PLoS One; 2011; 6(8):e24083. PubMed ID: 21918682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytology and human papillomavirus testing 6 to 12 months after ASCUS or LSIL cytology in organized screening to predict high-grade cervical neoplasia between screening rounds.
    Tropé A; Sjøborg KD; Nygård M; Røysland K; Campbell S; Alfsen GC; Jonassen CM
    J Clin Microbiol; 2012 Jun; 50(6):1927-35. PubMed ID: 22518869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus (HPV) E6/E7 mRNA detection in cervical exfoliated cells: a potential triage for HPV-positive women.
    Yao YL; Tian QF; Cheng B; Cheng YF; Ye J; Lu WG
    J Zhejiang Univ Sci B; 2017 Mar.; 18(3):256-262. PubMed ID: 28271661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women.
    Rezhake R; Hu SY; Zhao S; Xu XQ; Zhao XL; Zhang L; Wang Y; Zhang X; Pan QJ; Qiao YL; Zhao FH
    Int J Cancer; 2019 Jan; 144(1):34-42. PubMed ID: 29943809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV genotype determination and E6/E7 mRNA detection for management of HPV positive women.
    Bruno MT; Ferrara M; Fava V; Rapisarda A; Coco A
    Virol J; 2018 Mar; 15(1):52. PubMed ID: 29587778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic validity of the human papillomavirus E6/E7 mRNA test in cervical cytological samples of HC2-positive patients.
    Benevolo M; Terrenato I; Mottolese M; Marandino F; Carosi M; Rollo F; Ronchetti L; Muti P; Mariani L; Sindico S; Vocaturo G; Vocaturo A
    Cancer Causes Control; 2011 Jun; 22(6):869-75. PubMed ID: 21424209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus typing and viral gene expression analysis for the triage of women with abnormal results from papanicolaou test smears to colposcopy.
    Antonishyn NA; Horsman GB; Kelln RA; Severini A
    Arch Pathol Lab Med; 2009 Oct; 133(10):1577-86. PubMed ID: 19792047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of HPV detection technologies: Hybrid capture 2, PreTect HPV-Proofer and analysis of HPV DNA viral load in HPV16, HPV18 and HPV33 E6/E7 mRNA positive specimens.
    Keegan H; Mc Inerney J; Pilkington L; Grønn P; Silva I; Karlsen F; Bolger N; Logan C; Furuberg L; O'Leary J; Martin C
    J Virol Methods; 2009 Jan; 155(1):61-6. PubMed ID: 18955086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus genotype distribution and E6/E7 oncogene expression in Turkish women with cervical cytological findings.
    Tezcan S; Ozgur D; Ulger M; Aslan G; Gurses I; Serin MS; Giray BG; Dilek S; Emekdas G
    Asian Pac J Cancer Prev; 2014; 15(9):3997-4003. PubMed ID: 24935586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between high risk type human papillomavirus E6/E7 mRNA and cervical cancer].
    Wang XH; Qian YM; Miao L; Le Y; Du J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jul; 37(7):1003-5. PubMed ID: 27453113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic validity of human papillomavirus E6/E7 mRNA test in cervical cytological samples.
    Liu TY; Xie R; Luo L; Reilly KH; He C; Lin YZ; Chen G; Zheng XW; Zhang LL; Wang HB
    J Virol Methods; 2014 Feb; 196():120-5. PubMed ID: 24216236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.